A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis

Preliminary classification criteria for the cryoglobulinaemic vasculitis

(2011) S. De Vita et al.   ANNALS OF THE RHEUMATIC DISEASES

Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients

(2011) Maurizio Pietrogrande et al.   AUTOIMMUNITY REVIEWS

Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA

(2010) J. L. Nam et al.   ANNALS OF THE RHEUMATIC DISEASES

Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease

(2010) A. Petrarca et al.   BLOOD

Pegylated interferon- , ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study

(2010) F. Dammacco et al.   BLOOD

Rituximab plus Peg-interferon- /ribavirin compared with Peg-interferon- /ribavirin in hepatitis C-related mixed cryoglobulinemia

(2010) D. Saadoun et al.   BLOOD

Rituximab in ANCA-Associated Disease

(2010) Ronald J. Falk et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

(2010) Rachel B. Jones et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: Data from the French Autoimmunity and Rituximab registry

(2010) B. Terrier et al.   ARTHRITIS CARE & RESEARCH

Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: A long-term followup study of thirty-two patients

(2009) Benjamin Terrier et al.   ARTHRITIS AND RHEUMATISM

Rituximab may form a complex with iGmκ mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus–induced vasculitis

(2009) Damien Sène et al.   ARTHRITIS AND RHEUMATISM

Rituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases

(2009) M Ramos-Casals et al.   LUPUS

Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy

(2008) L Quartuccio et al.   ANNALS OF THE RHEUMATIC DISEASES

Relapse of hepatitis C virus–associated mixed cryoglobulinemia vasculitis in patients with sustained viral response

(2008) Dan-Avi Landau et al.   ARTHRITIS AND RHEUMATISM

Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: Targeting the infectious trigger, the autoimmune response, or both?

(2008) Salvatore De Vita et al.   AUTOIMMUNITY REVIEWS

Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis

(2008) D. Saadoun et al.   BLOOD

Diagnosis, management, and treatment of hepatitis C: An update

(2008) Marc G. Ghany et al.   HEPATOLOGY